Sahajanand Medical Technologies IPO Day 2: Subscription Status on 16 October 2026
- October 16, 2026
- Posted by: Harsh Piplani
- Category: IPO
Sahajanand Medical Technologies IPO Day 2, 16 Oct 2026. Subscribed 0.35x on Day 1: Retail 0.41x, QIB 0.37x, NII 0.20x. Price band Rs 327-344.
Quick Answer
The Sahajanand Medical Technologies IPO is on Day 2 of bidding on 16 October 2026. The issue was subscribed 0.35 times at the Day 1 reading on 15 October, with retail at 0.41 times, QIB at 0.37 times excluding the anchor portion and NII at 0.20 times. Bidding remains open until 19 October 2026, and investors should track the live category wise numbers on BSE and NSE through the day.
Sahajanand Medical Technologies Limited, a Surat-based medical devices maker, is on Day 2 of its IPO bidding window, which opened on 15 October 2026 and closes on 19 October 2026. The Sahajanand Medical Technologies IPO is a mainboard, book built issue worth about Rs 475.48 crore, entirely an offer for sale, and the shares are proposed to list on BSE and NSE.
Bids on Day 1 were for about 33.70 lakh shares against roughly 97.50 lakh shares on offer to the public, from 40,001 applications. Small NII bidders were at 0.36 times, big NII bidders at 0.13 times, and the employee category at 0.08 times.
Click Here – Get Free Investment Predictions
Sahajanand Medical Technologies IPO Details
The table below sets out the key parameters of the Sahajanand Medical Technologies IPO.
| Open Date | 15 October 2026 |
| Close Date | 19 October 2026 |
| Face Value | Re 1 per share |
| Price Band | Rs 327 to Rs 344 per share |
| Lot Size | 43 shares |
| Issue Size | Rs 475.48 crore (entirely offer for sale) |
| Issue Type | Book Built Issue, Mainboard |
| Listing At | BSE, NSE |
| Allotment Date | 21 October 2026 |
| Listing Date | 23 October 2026 |
Sahajanand Medical Technologies IPO Subscription Status Day 2
The table below tracks how the issue has moved through its bidding window, from the Day 1 close through to the Day 1 reading on Thursday, 15 October.
| Session | Overall | QIB | NII | Retail |
|---|---|---|---|---|
| Day 1 close (15 Oct) | 0.35x | 0.37x | 0.20x | 0.41x |
| Day 2, so far (16 Oct) | Updating through the session | |||
NII demand was the softest segment on opening day, and large bids in mainboard issues often arrive in the final hours. Figures are the NSE reading at about 5 PM on 15 October, so confirm final numbers on NSE or BSE as bidding continues until 19 October.
Track Subscription Status for the issue on the Univest Screener
How to Apply for the Sahajanand Medical Technologies IPO
- Open a Demat and trading account with a SEBI-registered broker such as Univest if you do not already have one.
- Select the issue on your broker app or net banking platform and enter your bid quantity and price within the Rs 327 to Rs 344 band, in multiples of 43 shares.
- Submit the application through the UPI-based ASBA method so the bid amount is blocked rather than debited immediately.
- Approve the UPI mandate on your phone before the daily cut off time, keeping in mind the issue closes on 19 October.
Download the Univest iOS App or Univest Android App to apply for the issue before the 19 October close.
Grey market premium (GMP) is an unofficial, unregulated indicator for the issue that is not endorsed by SEBI, NSE, or BSE. Investors looking for indicative GMP data can go through other relevant sources, though such figures should never be the sole basis for an investment decision.
Conclusion
The issue enters Day 2 at 0.35 times, with retail and QIB ahead of NII. Investors considering the issue should weigh the valuation against listed peers such as Poly Medicure and the pricing pressure on stents, and read the RHP on bseindia.com before applying after independent due diligence.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
FAQs
What is the Sahajanand Medical Technologies IPO subscription status on Day 2?
Ans. The issue carries forward a Day 1 close of 0.35 times overall, with retail at 0.41 times, QIB at 0.37 times and NII at 0.20 times, and figures for Day 2, 16 October 2026, are updating through today’s session on BSE and NSE.
When does the Sahajanand Medical Technologies IPO close?
Ans. The issue closes for subscription on 19 October 2026, having opened on 15 October 2026.
What is the Sahajanand Medical Technologies IPO price band and lot size?
Ans. The issue price band is Rs 327 to Rs 344 per share, with a lot size of 43 shares. A retail investor needs at least one lot, which is about Rs 14,792 at the upper price band.
Is the Sahajanand Medical Technologies IPO fully subscribed?
Ans. Not yet. The issue was subscribed 0.35 times at the Day 1 reading on 15 October, with retail at 0.41 times, QIB at 0.37 times excluding the anchor portion and NII at 0.20 times.
What is the Sahajanand Medical Technologies IPO GMP?
Ans. Grey market premium (GMP) is an unofficial, unregulated indicator for the issue that is not endorsed by SEBI, NSE, or BSE. Investors looking for indicative GMP data can go through other relevant sources, though such figures should never be the sole basis for an investment decision.
How do I apply for the Sahajanand Medical Technologies IPO?
Ans. You can apply for the issue through your SEBI-registered broker or UPI-enabled banking app using the ASBA method, enter your bid quantity and price within the Rs 327 to Rs 344 band, in multiples of 43 shares, then approving the UPI mandate before the daily cut off.
When will the Sahajanand Medical Technologies IPO be allotted and listed?
Ans. The issue allotment is expected to be finalised on 21 October 2026, with listing on BSE and NSE tentatively scheduled for 23 October 2026.
What does Sahajanand Medical Technologies Limited do?
Ans. Sahajanand Medical Technologies Limited makes Class III and Class C and D medical devices, mainly for vascular and structural heart intervention, and is based in Surat.
